Edgewise Therapeutics
EWTX
EWTX
129 hedge funds and large institutions have $1.67B invested in Edgewise Therapeutics in 2024 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 59 increasing their positions, 29 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
51% more call options, than puts
Call options by funds: $408K | Put options by funds: $270K
11% more funds holding
Funds holding: 116 → 129 (+13)
27.45% less ownership
Funds ownership: 125.86% → 98.41% (-27%)
Holders
129
Holding in Top 10
5
Calls
$408K
Puts
$270K
Top Buyers
| 1 | +$163M | |
| 2 | +$49.7M | |
| 3 | +$44.6M | |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$41.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.5M |
Top Sellers
| 1 | -$66.4M | |
| 2 | -$51.4M | |
| 3 | -$40.9M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$27.8M |
| 5 |
DM
Deerfield Management
New York
|
-$19.3M |